Drug & intervention

canrenone

RxCUI 1982

How to interpret these research links

Connected source records

CureCurrent currently connects this RxNorm drug concept to 3 displayed clinical trials and 3 distinct registered condition labels on this page. The links show what was studied, not whether this drug is effective or approved for those conditions. FDA-label excerpts, when available, refer to specific labeled products and may include route and formulation restrictions.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

What this record represents

IN · RxNorm

This is an RxNorm IN drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

Research activity for this drug concept

Published registry records

Study starts and current recruitment statuses across 3 distinct linked trials. This measures registered research activity, not medical effectiveness or FDA approval.

Reported start-year cohortsRegistered start year; the green segment is the subset reported as recruiting in the current snapshot. The current year may be incomplete.
All other statuses Currently recruiting
Current recruiting and other trial statusesCurrent ClinicalTrials.gov status snapshot for linked trials.
COMPLETED2 (66.7%)
UNKNOWN1 (33.3%)

Related drug records

RxNorm name matches

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.

No other matching drug records are currently published. This does not mean they do not exist in RxNorm.

Molecular structure

Verified RxNorm ingredient illustration
Molecular structure illustration of canrenone
RxNorm RxCUI 1982 · PubChem CID 13789 · C22H28O3. Verify structure at PubChem. This drawing represents the matched chemical ingredient, not necessarily a complete multi-ingredient branded product.
Clinical trials3
Recruiting0
Related conditions3
Synonyms2
Advertisement

Conditions in registry-name-matched drug studies

ClinicalTrials.gov intervention names begin with this ingredient name. These are text matches, not verified RxNorm mappings, evidence of treatment efficacy, or approved indications. Different salts or formulations may be involved.

Atrial Fibrillation, Paroxysmal1 Cardiac Heart Failure Patients1 Essential Hypertension1 Heart Failure1

Matching published trials

Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF StudyNCT00403910 · COMPLETED
Canrenone as Add-on in Patients With Essential HypertensionNCT02687178 · COMPLETED
Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)NCT03263962 · COMPLETED
Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.NCT03536806 · UNKNOWN
Advertisement

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.